Education
About Us
Working with TipRanks
Follow Us
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
RESEARCH TOOLSreports
Comparison Results
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$28.20
HK$13.21B
16.12
-4.02%
0 Buy
0 Hold
0 Sell
Moderate Buy
Ascletis Pharma, Inc.
HK$13.25
HK$14.01B
―
1454.22%
1 Buy
1 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$9.09
HK$17.49B
―
275.62%
0 Buy
0 Hold
0 Sell
Hold
CARsgen Therapeutics Holdings Ltd.
HK$21.50
HK$12.93B
―
495.57%
0 Buy
0 Hold
1 Sell
Moderate Sell
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$21.22
HK$8.84B
241.39
231.11%
0 Buy
0 Hold
0 Sell
Hold
Performance Comparison
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
27.68
-2.41
-8.01%
HK:1672
Ascletis Pharma, Inc.
12.90
12.07
1454.22%
HK:2157
Lepu Biopharma Co. Ltd. Class H
9.09
6.66
274.07%
HK:2162
Keymed Biosciences, Inc.
66.50
33.25
100.00%
HK:2171
CARsgen Therapeutics Holdings Ltd.
21.50
18.07
526.82%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
20.86
14.49
227.47%